Allos Therapeutics Inc. (ALTH) Stock Quote

Detailed Quote for Allos Therapeutics Inc. (ALTH)

close 52 Week Information

52 Week High

February 28, 2011

Close: 3.42

52 Week Low

December 13, 2011

Close: 1.25

Today

Last Price
1.70

Change $
0.06

Change %
3.41%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
1.75

High
1.75

Low
1.68

Prev Close
1.76

Last Trade
2/10/12

Volume
227.62 k

52 Wk Hi
3.42

52 Wk Low
1.25

Market Cap
180.07 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
105,926,068

EPS (TTM)
-0.41

PE Ratio
N/A

close Exchange Information Listed On Nasdaq Global Select (NGS) Exchange
NGS

News and Media for Allos Therapeutics Inc. (ALTH)

Sector News | Topic News

News for ALTH

Mon, Jan 30, 2012

8:30 AM

Allos Therapeutics Requests Re-Examination of CHMP Opinion on FOLOTYN® in PTCL at the European Medicines Agency - Business Wire

8:00 AM

Allos Therapeutics Announces Interim Results from Phase 1 Combination Study of FOLOTYN® and Bexarotene Demonstrate Activity in Patients with Relapsed or Refractory Cutaneous T-cell Lymphoma - Business Wire

Fri, Jan 20, 2012

7:43 AM

Allos Therapeutics Receives Negative Opinion from the CHMP on FOLOTYN - Business Wire

Tue, Jan 10, 2012

8:00 AM

Allos Therapeutics Reports 2011 Financial Highlights and Key Business Priorities - Business Wire

Wed, Dec 21, 2011

8:00 AM

Allos Therapeutics Invites Investors to Listen to Webcast of Presentation at J.P. Morgan Healthcare Conference - Business Wire

Thu, Oct 13, 2011

8:16 AM

Strong Pipelines From Allos Therapeutics and Dynavax Tech Poised to Pay Off - Marketwire

Fri, Jun 17, 2011

9:00 AM

Research Report on Allos Therapeutics, Inc. and Spectrum Pharmaceuticals, Inc. -- BioPharm Looks Forward for Growth - Marketwire

Mon, May 02, 2011

8:16 AM

Oncology Drug Makers Positioned for Long Term Growth - Marketwire

Thu, Mar 17, 2011

10:51 AM

Speculative Biotech Firms Remain Popular Takeover Targets - Marketwire

Tue, Aug 07, 2007

8:07 AM

Allos Therapeutics Reports Second Quarter 2007 Financial Results - Canada Newswire

More News for ALTH >>

Tags for Allos Therapeutics Inc.

Research stocks or mutual funds related to Allos Therapeutics Inc. by keywords or tags. Find companies that have a similar focus to ALTH. The keywords below have been associated to ALTH by either user submission or electronic means.

cellular phone radiation lung cancer research clinical trials database healthcare jobs clinical trial logistics stem cell therapeutics clinical trial enrollment clinical trials liability radiation exposure clinical research trial clinical trials data lymphedema treatment abra therapeutics breast cancer new treatment clinical pharmacology cv therapeutics stock therapy treatment annual report nuclear radiation trimeris clinical trial process clinical trial jobs small molecule nektar therapeutics amicus therapeutics phase iii clinical trials romania clinical research healthcare furniture cell phone radiation blocker prostate cancer val d allos california treatment pancreatic cancer cv therapeutics clinical research clinical trial manager enrollment clinical trials earth therapeutics vaccine trials leukemia patients annual report printing clinical trial india radiation mesothelioma treatment option chemotherapy breast cancer paid clinical trial phase 3 clinical trials clinical trials directive clinical trials manager fda clinical trial